The relative contribution of microenvironmental interactions to the regulation of gene expression programs in multiple myeloma cells Liat Nadav Molecular.

Slides:



Advertisements
Similar presentations
รายงานการลาศึกษาต่อป.โท-ป.เอก
Advertisements

Kwee Yong, UCL Cancer Institute
Cancer Stem Cells, Clonal Heterogeneity and
Notch receptor and ligands Receptor isoforms: Notch 1-4 Ligands: jagged 1, jagged 2, delta1, delta2, delta 3, delta 4 Microenviroment of bone marrow.
Stable epigenetic reprogramming of bone marrow MSC in patients with MM Sarah Essex.
TODAY B CELL DEVELOPMENT.
Course Code Course Title Credits BMS 500 Responsible Conduct of Research 1 BMS 510F Biochemistry and Cell Biology 10 BMS 512 Critical Thinking 1 BMS 523A.
Differentiation Cell & Molecular Biology. Genetic Control All cells in the body have the same genetic information Not all cells are identical. Cellular.
The Story of Bcl-2 Linking cell apoptosis to tumor metastasis Crystal structure of Bcl-2 complex By Yaming Wang.
MOLECULAR GENETICS OF B CELL LYMPHOMAS: AN UPDATE Michel Trudel, MD, FRCPC Shaikh Khalifa Medical Center.
Cell Identity Determined by types and amounts of proteins in the cell
Outline Immunoglobulin Superfamily Antigen Recognition Members:
27803::Systems Biology1CBS, Department of Systems Biology Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break.
Chris Chander, Luke Adea BioSci D145 Feb. 12, 2015
Generation of antibodies and T cell receptors by V(D)J recombination Lymphocyte development: generation of cells with functional and useful antigen receptors.
Chapter 14 B Lymphocytes. Contents  B cell receptor and B cell complex  B cell accessory molecules  B cell subpopulations  Functions of B cells 
Malignant Melanoma and CDKN2A
Chapter 11 B-Cell Generation, Activation, and Differentiation.
1 B Cell repertoire - role of B cell antigen receptors (BCR)
Control of gene expression Transcriptional Post-transcriptional Epigenetics and long range control.
Lymphocyte Development & Generation of Lymphocyte Antigen Receptors Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1. Abbas, A,
Normal haemopoiesis. ABNORMALITIES IN THE HEMOPOIETIC SYSTEM CAN LEAD TO HEMOGLOBINOPATHIES HEMOPHILIA DEFECTS IN HEMOSTASIS/THROMBOSIS HEMATOLOGICAL.
Basic Immunology University of Tabuk Faculty of Applied Medical Science Department of Medical Laboratory Technology Mr.AYMAN.S.YOUSIF MSc.Medical Microbiology.
Jianzhong Chen, Ph.D. Institute of Immunology, ZJU.
Fig Fig Gene for a glycolysis enzyme Hemoglobin gene Antibody gene Insulin gene White blood cell Pancreas cell Nerve cell Active gene Key.
Transcriptomics Sequencing. over view The transcriptome is the set of all RNA molecules, including mRNA, rRNA, tRNA, and other non coding RNA produced.
Role of Immunoglobulin Gene Expression in Acute Myeloid Leukemia C. Cameron Yin, MD, PhD Department of Hematopathology University of Texas MD Anderson.
Cell Communication Chapter Cell Communication: An Overview  Cells communicate with one another through Direct channels of communication Specific.
Stephanie J. Culler, Kevin G. Hoff, Christina D. Smolke
Telomerase, Immortalization and Cancer Eric Bankaitis Cancer Bio 169 March 9, 2006 Fig.[9]
Identification of co-expression networks by comparison of a multitude of different functional states of genome activity Marc Bonin 1, Stephan Flemming.
GO-Slim term Cluster frequency cytoplasm 1944 out of 2727 genes, 71.3% 70 out of 97 genes, 72.2% out of 72 genes, 86.1% out.
Cell lineXY11q WM WM793-P WM793-P Lu ABAB WM793:WM793-P2WM793:1205-Lu WM793 WM793:WM793-P1 Supplemental.
THE IMMUNOPATHOGENESIS OF HIV INFECTION Lymphotropic virus.
Dr. Hiba Wazeer Al Zou’bi
Chapter 5 Organization and Expression of Immunoglobulin Genes Dr. Capers.
Therapies targeting the Immune System:  Stimulation  Suppression  Modulation.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Multiple Myeloma Precursor Disease JAMA. 2010;304(21):
Identification of Cancer Stem Cells using Flow Cytometry Analysis تعيين الخلايا الجذعية السرطانية باستخدام تحليل التدفق الخلوي Dr. Ayat Al-Ghafari Biochemistry.
IMMUNOLOGICAL TOLERANCE. BASIC FACTS ABOUT TOLERANCE Tolerance – a state of unresponsiveness specific for a given antigen It is specific (negative) immune.
Lactate dehydrogenase is crucial for tumor associated macrophage protection of multiple myeloma cells against chemotherapy Carolyn Stierhoff, Enguang Bi,
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
M1 – Immunology EFFECTOR T CELL FUNCTIONS (Part I) March 27, 2009 Ronald B. Smeltz, Ph.D. Microbiology and Immunology
B-cell receptor signaling in chronic lymphocytic leukemia
Cellular Immune response
AN ATTEMPT TO REVERSE CANCER DRUG RESISTANCE
Telomerase reverse transcriptase in the regulation of gene expression
Dept of Biomedical Informatics University of Pittsburgh
MRD in Myeloma: the Future is Here
Fig. 1. TP is highly expressed in myeloma.
Immunogenetics Lecture 3: TcR.
Antibody production and B cell differentiation
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells by Toshihiko Tanno, Yiting Lim, Qiuju.
BTK inhibition in myeloma: targeting the seed and the soil
by Malte Peters, Albrecht M. Müller, and Stefan Rose-John
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Cancer stem cells and their application into targeted therapy for cancer Mol. Bio. Lab Park Ji Won Supervisor ; Dae Youn Hwang.
Noninvasive Molecular Monitoring in Multiple Myeloma Patients Using Cell-Free Tumor DNA  Giulia Biancon, Silvia Gimondi, Antonio Vendramin, Cristiana.
The transcriptional program of terminal granulocytic differentiation
Unit III Information Essential to Life Processes
Mechanisms of immune escape in the tumor microenvironment.
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
Schematic model of effector pathways that mediate tumor suppression by p53. Schematic model of effector pathways that mediate tumor suppression by p53.
Single Cell Regulatory Variation
MicroRNA Control in the Immune System: Basic Principles
by Yue Wei, Hong Zheng, Naran Bao, Shan Jiang, Carlos E
and Other Unstable mRNAs
Long Noncoding RNAs in Cancer Pathways
Volume 27, Issue 5, Pages (May 2019)
Phenotypic diversity of less predominant B-lineage clones.
Presentation transcript:

The relative contribution of microenvironmental interactions to the regulation of gene expression programs in multiple myeloma cells Liat Nadav Molecular Cell Biology Department Weizmann Institute of Science The Hematology Institute Tel-Aviv Sourasky Medical Center Bentzi Katz, PhD The Hematology Institute Tel-Aviv Sourasky Medical Center

Diversity – a hallmark of tumor progression BM growth Dissemination Osteoclast activation Drug resistance I Drug resistance II Drug resistance III

Diversity - is it a stochastic process, or is there any direction, regulation ?

monocyte lymphocyte neutrophil platelets RBC Bone marrow Bone marrow

Regulation of Megakarypoiesis by BM niches Regulation of Megakarypoiesis by BM niches (Rafii S. et al., ) Soluble factors Cellular interactions Adhesive interactions

Can adhesive interactions generate diversity of malignant plasma cells ? What is the physiological significance of such a process ?

Isolation of adhesive variants from the ARH-77 line Type-F cells (floating) Type-A cells (adherent) No. of events CD138 Type-A Type-F Flow cytometry pattern

Type-A cells Type-F cells Differential gene expression in adhesive variants I II III IV V I II III IV V 5 individual enrichmentsRNA purificationAffymetrix array

Percent of genes in each function category Metabolism Signal transduction Transport Differentiation and Development Transcription factors Apoptosis Cell cycle Adhesion Motility Immune response Undefined Color Code Type-A cells Type-F cells Assignment of gene expressed in adhesive variants

Coding region Regulatory region Regulatory elements Gene A Gene B Gene C Gene D RNA from cell I Pathway X is active in cell I Gene A Gene B Gene C Gene D RNA from cell II Pathway Y is active in cell II Signaling pathways Promotor analysis

Type-A cellsType-F cells ? NF  B ( CCND1, CXCL11, IL6) EGR (c-jun, EGR1, EGR2) NF  B1 SRF NF  B2

L1 L2 L3 L4 L5 L6 L7 L8 L9 L10 H1 H2 H3 H4 H5 H6 H7 H8 H Average expression in Type F Average expression in Type A B-Cell differentiation state LowHigh L1- TIMP1H1- GADD45A L2- BCL6H2- IgH VDJ L3- IL-6H3- IgH variable L4- EGR4H4- Ig rearranged L5- TNFH5- IgH HM L6- TNFRSF2H6- IgH J L7- TNFRSF4H7- IgH G1-4 L8- TNFRSF9H8- IgH M L9- MYCNH9- IgH M1-2 L10- BTK Cell adhesion regulates differentiation of plasma cells GAPDH FA IgJ GAPDH FA EGR1

Type-A cells AF cells GAPDH EGR1 IgJ Type-A cells AF cells Regulation of gene expression is reversible

Lapsed time (days) Tumor Free mice (%) Type-A cells Type-F cells Malignancy potential of plasma cell variants

1.Microenvironmental interactions can generate diversity of malignant plasma cells 2. Directional diversity – differentiation 3. Specific putative targets: NF  B, EGR (Type-A) 4. Type-A cells – are they represent “stem cells” or “stem state” ? Phenotype control by microenvironmental interactions

CD138 CD38 Control Mechanical +enzymes Spicules Patient BMs also contain diverse MM cells Fluid MM bone marrow

Thanks… Benny Geiger Molecular Cell Biology Department Weizmann Institute of Science Tal Shay, Eytan Domany Physics of Complex Systems Department Weizmann Institute of Science Ella Naparstek Shoshie Baron The Hematology Institute Tel-Aviv Sourasky Medical Center